Hair loss after routine immunizations

JAMA

Volumn 278, Issue 14, 1997, Pages 1176-1178

  Wise, Robert P ^a,d   Kiminyo, Kitonga P ^a,b,c   Salive, Marcel E ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c WASHINGTON HOSPITAL CENTER   (United States)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS VACCINE; INFLUENZA VACCINE;

ADULT; ALOPECIA; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; IMMUNIZATION; INFANT; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0030815655     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.278.14.1176     Document Type: Article

References (22)

1. Pillans PI, Woods DJ. Drug-associated alopecia. Int J Dermatol. 1995;34:149-158.
2. Chen RT. Special methodological issues in pharmacoepidemiology studies of vaccine safety. In: Strom BL, ed. Pharmacoepidemiology. 2nd ed. Chichester, England: John Wiley & Sons Inc; 1994: 581-594.
3. Chen RT, Rastogi SC, Mullen JR, et al. The Vaccine Adverse Event Reporting System (VAERS). Vaccine. 1994;12:542-549.
4. Centers for Disease Control and Prevention. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep. 1991;40(RR-13):11-13.
5. Russell S. Parents wonder about hepatitis B vaccine, 2-year-old has lost her hair - twice - but doctors say benefits outweigh risks. San Francisco Chronicle. April 21, 1994:A17, A21.
6. Karch FE, Lasagne L. Toward the operational identification of adverse drug reactions. Clin Pharmacol Ther. 1977;21:247-254.
7. Kramer MS, Leventhal JM, Hutchinson TA, Feinstein AR. An algorithm for the operational assessment of adverse drug reactions, I: background, description, and instructions for use. JAMA 1979;242: 623-632.
8. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245.
9. Jones JK. Adverse reactions in the community health setting: approaches to recognizing, counseling, and reporting. Fam Community Health. 1982; 5:58-67.
10. Bégaud B, Evreux JC, Jouglard J, Lagier G. Unexpected or toxic drug reaction assessment (imputation): actualization of the method used in France. Therapie. 1985;40:115-118.
11. Jones JK. Determining causation from case reports. In: Strom BL, ed. Pharmacoepidemiology. 2nd ed. Chichester, England: John Wiley & Sons Inc; 1994:365-378.
12. Council for International Organizations of Medical Sciences (CIOMS). Guidelines for Preparing Core Clinical Safety Information on Drugs: Report of CIOMS Working Group III. Geneva, Switzerland: CIOMS; 1995.
13. Bolognia J, Braverman IM. Skin manifestations of internal disease. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, eds. Harrison's Principles of Internal Medicine. 13th ed. New York, NY: McGraw-Hill Book Co; 1994:290-307.
14. Petkov I, Bozdekov B, Kapnilov S, Sankov N. Cutaneous symptoms of complications following smallpox vaccination [in Bulgarian]. Kat Kozhni Ven Bol. 1973;12:39-42.
15. Tosti A, Misciali C, Piraccini BM, Peluso AM, Bardazzi F. Drug-induced hair loss and hair growth: incidence, management, and avoidance. Drug Saf. 1994;10:310-317.
16. Llau M-E, Viraben R, Montastruc J-L. Les alopécies médicamenteuses: revue de la littérature. Therapie. 1995;50:145-150.
17. Wood AJ. Adverse reactions to drugs. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, eds. Harrison's Principles of Internal Medicine. 13th ed. New York, NY: McGraw-Hill Book Co; 1994:405-412.
18. Wintroub BU, Stern RS. Cutaneous drug reactions. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, eds. Harrison's Principles of Internal Medicine. 13th ed. New York, NY: McGraw-Hill Book Co; 1994:279-285.
19. Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton LJ. Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc. 1995;70:628-633.
20. Skinner RB, Light WH, Bale GF, Rosenberg EW, Leonardi C. Alopecia areata and presence of cytomegalovirus DNA. JAMA 1995;273:1419.
21. Abel EA, Farber EM. Disorders of pigmentation, hair, nails, and oral mucosa. In: Dale DC, Federman DD, eds. Scientific American Medicine, II: Dermatology. New York, NY: Scientific American; 1993:1-16.
22. Chen RT, Glasser JW, Rhodes PH, et al. Vaccine Safety Datalink Project: a new tool for improving vaccine safety monitoring in the United States. Pediatrics. 1997;99:765-773.